{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T06:31:25Z","timestamp":1768890685209,"version":"3.49.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"24","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.vaccine.2009.02.075","type":"journal-article","created":{"date-parts":[[2009,3,6]],"date-time":"2009-03-06T10:49:40Z","timestamp":1236336580000},"page":"3234-3236","source":"Crossref","is-referenced-by-count":9,"title":["The strategy for prevention of measles and rubella prevalence with measles\u2013rubella (MR) vaccine in Japan"],"prefix":"10.1016","volume":"27","author":[{"given":"Toshiaki","family":"Ihara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.02.075_bib1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/oxfordjournals.epirev.a036121","article-title":"Herd immunity: history, theory, practice","volume":"15","author":"Fine","year":"1993","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.vaccine.2009.02.075_bib2","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(98)02364-2","article-title":"Effect of subclinical infection on maintaining immunity against measles in vaccinated children in west Africa","volume":"353","author":"Whittle","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2009.02.075_bib3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00006454-199503000-00007","article-title":"Serologic status and measles attack rates among vaccinated and unvaccinated children in rural Senegal","volume":"14","author":"Samb","year":"1995","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2009.02.075_bib4","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/1096-9071(200012)62:4<511::AID-JMV17>3.0.CO;2-Z","article-title":"Protective titers of measles neutralizing antibody","volume":"62","author":"Lee","year":"2000","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2009.02.075_bib5","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1086\/522868","article-title":"Building an immunity fence against measles","volume":"196","author":"Orenstein","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.02.075_bib6","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/ajcp\/106.2.170","article-title":"Rubella immunity: defining the level of protective antibody","volume":"106","author":"Skendzel","year":"1996","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.vaccine.2009.02.075_bib7","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1086\/313926","article-title":"Factors determining prevalence of maternal antibody to measles virus throughout infancy: a review","volume":"31","author":"Caceres","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2009.02.075_bib8","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/00006454-200007000-00010","article-title":"Placental transfer and decay of maternally acquired antimeasles antibodies in Nigerian children","volume":"19","author":"Hartter","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2009.02.075_bib9","unstructured":"Ihara T, Nakano T, Kamiya H, Nii R, Isaji M. The timing of measles, rubella, mumps, and varicella vaccination according to the antibody titers in the cord blood. The survey on study group of vaccination; 2005. p. 72\u20134 (in Japanese)."},{"key":"10.1016\/j.vaccine.2009.02.075_bib10","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/S0264-410X(98)00081-4","article-title":"Vaccine-induced measles virus antibodies after two doses of combined measles, mumps and rubella vaccine: a 12-year follow-up in two cohorts","volume":"16","author":"Davidkin","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.02.075_bib11","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.1016\/S0264-410X(01)00239-0","article-title":"Measles seroepidemiology and decay rate of vaccine-induced measles IgG titers in Taiwan, 1995\u20131997","volume":"19","author":"Lee","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.02.075_bib12","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1056\/NEJMoa066092","article-title":"Duration of humoral immunity to common viral and vaccine antigens","volume":"357","author":"Amanna","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2009.02.075_bib13","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/00006454-199907000-00010","article-title":"Increased protections during a measles outbreak of children previously vaccinated with a second dose of measles\u2013mumps\u2013rubella vaccine","volume":"18","author":"Vitek","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2009.02.075_bib14","series-title":"Vaccines","first-page":"389","article-title":"Measles vaccine","author":"Strebel","year":"2004"},{"key":"10.1016\/j.vaccine.2009.02.075_bib15","first-page":"53","article-title":"Changing levels of measles antibody titers in women and children in the United States: impact on response to vaccination","volume":"97","author":"Markowitz","year":"1996","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2009.02.075_bib16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/jmv.1890450220","article-title":"Measles antibodies in women and infants in the vaccine era","volume":"45","author":"Kacica","year":"1995","journal-title":"J Med Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09003120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09003120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T13:39:38Z","timestamp":1558186778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09003120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":16,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0264410X09003120"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.02.075","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}